{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:08:54Z","timestamp":1788541734874,"version":"build-2803163510"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":3416,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Orion Ltd"},{"name":"CEVA Animal Health Ltd"},{"DOI":"10.13039\/501100003551","name":"Royal Canin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003551","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Petsavers"},{"name":"Petplan"},{"DOI":"10.13039\/100007054","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vetoquinol"},{"DOI":"10.13039\/100012895","name":"Zoetis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertension is a common problem in elderly cats. In most cats, systolic blood pressure (SBP) of &amp;lt;160 mmHg is achieved in response to amlodipine besylate at either 0.625 or 1.25 mg q24h. The individual cat factors determining dose requirement dose have not been explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To determine whether individual cat factors influence the dose of amlodipine required to achieve adequate blood pressure control and to determine whether factors other than the prescribed dose of drug alter the achieved plasma amlodipine concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fifty-nine hypertensive cats that required 0.625 mg (A) and 41 cats that required 1.25 mg (B) amlodipine to reach a target SBP of &amp;lt;160 mmHg were identified, and plasma amlodipine concentrations were determined. Comparisons were made between groups, and multivariable linear regression models were performed to investigate predictors of antihypertensive response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cats that required a greater dose of amlodipine had significantly higher SBP at diagnosis of hypertension (A: (median [25th, 75th percentile]) 182 [175,192] mmHg; B: 207 [194,217] mmHg, P &amp;lt; .001), but comparable blood pressure was achieved after treatment. Plasma amlodipine concentrations were directly related to the dose of amlodipine administered. At diagnosis, cats in group B had significantly lower plasma potassium concentration (A: 4.1 [3.8,4.5]; B: 3.8 [3.6,4.2] mEq\/L, P &amp;lt; .01). Weight did not differ between groups. The decrease in SBP was directly and independently associated with the SBP at diagnosis and the plasma amlodipine concentration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Cats with higher blood pressure at diagnosis might require a greater dose of amlodipine to control their blood pressure adequately. Differences in amlodipine pharmacokinetics between cats do not seem to play a role in the antihypertensive response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.14562","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T09:15:36Z","timestamp":1474535736000},"page":"1630-1636","source":"Crossref","is-referenced-by-count":27,"title":["Factors Influencing the Relationship Between the Dose of Amlodipine Required for Blood Pressure Control and Change in Blood Pressure in Hypertensive Cats"],"prefix":"10.1093","volume":"30","author":[{"given":"E.S.","family":"Bijsmans","sequence":"first","affiliation":[{"name":"Royal Veterinary College, University of London Department of Comparative Biomedical Sciences, , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Doig","sequence":"additional","affiliation":[{"name":"ABS Laboratories Ltd , Welwyn Garden City, Hertfordshire,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Jepson","sequence":"additional","affiliation":[{"name":"Royal Veterinary College, University of London Department of Clinical Science and Services, , Hatfield, Hertfordshire,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Syme","sequence":"additional","affiliation":[{"name":"Royal Veterinary College, University of London Department of Clinical Science and Services, , Hatfield, Hertfordshire,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Elliott","sequence":"additional","affiliation":[{"name":"Royal Veterinary College, University of London Department of Comparative Biomedical Sciences, , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pelligand","sequence":"additional","affiliation":[{"name":"Royal Veterinary College, University of London Department of Clinical Science and Services, , Hatfield, Hertfordshire,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"key":"2026020303121923100_jvim14562-bib-0001","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1939-1676.2007.tb03005.x","article-title":"Guidelines for the indentification, evaluation, and management of systemic hypertension in dogs and cats","volume":"21","author":"Brown","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020303121923100_jvim14562-bib-0002","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"2026020303121923100_jvim14562-bib-0003","first-page":"147","article-title":"Evaluation of the antihypertensive agent amlodipine besylate in normotensive cats and a cat with systemic hypertension (abstract)","volume":"8","author":"Snyder","year":"1994","journal-title":"J Vet Intern Med"},{"key":"2026020303121923100_jvim14562-bib-0004","first-page":"145","article-title":"Amlodipine besylate therapy in cats with systemic hypertension secondary to chronic renal disease (abstract)","volume":"8","author":"Henik","year":"1994","journal-title":"J Vet Intern Med"},{"key":"2026020303121923100_jvim14562-bib-0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1939-1676.1998.tb02111.x","article-title":"Amlodipine: a randomized, blinded clinical trial in 9 cats with systemic hypertension","volume":"12","author":"Snyder","year":"1998","journal-title":"J Vet Intern Med"},{"key":"2026020303121923100_jvim14562-bib-0006","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/jvim.12589","article-title":"Randomized placebo-controlled clinical trial of a chewable formulation of amlodipine for the treatment of hypertension in client-owned cats","volume":"29","author":"Huhtinen","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020303121923100_jvim14562-bib-0007","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1939-1676.1998.tb02107.x","article-title":"Calcium channel blockers in veterinary medicine","volume":"12","author":"Cooke","year":"1998","journal-title":"J Vet Intern Med"},{"key":"2026020303121923100_jvim14562-bib-0008","doi-asserted-by":"crossref","first-page":"2A","DOI":"10.1016\/0002-9149(94)90268-2","article-title":"Unique pharmacologic properties of amlodipine","volume":"73","author":"Burges","year":"1994","journal-title":"Am J Cardiol"},{"key":"2026020303121923100_jvim14562-bib-0009","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1748-5827.2001.tb02008.x","article-title":"Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases","volume":"42","author":"Elliott","year":"2001","journal-title":"J Small Anim Pract"},{"key":"2026020303121923100_jvim14562-bib-0010","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5326\/15473317-33-3-226","article-title":"Treatment of systemic hypertension in cats with amlodipine besylate","volume":"33","author":"Henik","year":"1997","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303121923100_jvim14562-bib-0011","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/jvim.12600","article-title":"Changes in systolic blood pressure over time in healthy cats and cats with chronic kidney disease","volume":"29","author":"Bijsmans","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020303121923100_jvim14562-bib-0012","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2460\/javma.2002.220.1799","article-title":"Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation","volume":"220","author":"Syme","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303121923100_jvim14562-bib-0013","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/jvim.12240","article-title":"Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate","volume":"28","author":"Jepson","year":"2014","journal-title":"J Vet Intern Med"},{"key":"2026020303121923100_jvim14562-bib-0014","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/vr.161.21.711","article-title":"Changes in the glomerular filtration rate of 27 cats with hyperthyroidism after treatment with radioactive iodine","volume":"161","author":"Boag","year":"2007","journal-title":"Vet Rec"},{"key":"2026020303121923100_jvim14562-bib-0015","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"2026020303121923100_jvim14562-bib-0016","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/HJH.0b013e3282fcc37f","article-title":"Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study","volume":"26","author":"Suonsyrja","year":"2008","journal-title":"J Hypertens"},{"key":"2026020303121923100_jvim14562-bib-0017","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00004872-199308000-00011","article-title":"Amlodipine and lisinopril in combination for the treatment of essential hypertension: efficacy and predictors of response","volume":"11","author":"Cappuccio","year":"1993","journal-title":"J Hypertens"},{"key":"2026020303121923100_jvim14562-bib-0018","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1523-1755.2002.00200.x","article-title":"Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension","volume":"61","author":"Chapman","year":"2002","journal-title":"Kidney Int"},{"key":"2026020303121923100_jvim14562-bib-0019","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/clpt.1990.120","article-title":"Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition","volume":"48","author":"Abernethy","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"2026020303121923100_jvim14562-bib-0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1098612X15572035","article-title":"Clinical findings, diagnostics and outcome in 33 cats with adrenal neoplasia (2002\u20132013)","volume":"18","author":"Daniel","year":"2015","journal-title":"J Feline Med Surg"},{"key":"2026020303121923100_jvim14562-bib-0021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cvsm.2010.09.004","article-title":"Chronic kidney disease in small animals","volume":"41","author":"Polzin","year":"2011","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303121923100_jvim14562-bib-0022","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11906-006-0013-z","article-title":"Sodium transporters in the distal nephron and disease implications","volume":"8","author":"Ecelbarger","year":"2006","journal-title":"Curr Hypertens Rep"},{"key":"2026020303121923100_jvim14562-bib-0023","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fphys.2013.00388","article-title":"Disturbed acid-base transport: an emerging cause of hypertension","volume":"4","author":"Boedtkjer","year":"2013","journal-title":"Front Physiol"},{"issue":"5","key":"2026020303121923100_jvim14562-bib-0024","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1098612X13495241","article-title":"Feline CKD: current therapies\u2014what is achievable?","volume":"15","author":"Korman","year":"2013","journal-title":"J Feline Med Surg"},{"key":"2026020303121923100_jvim14562-bib-0025","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1034\/j.1399-6576.2003.00181.x","article-title":"Severe intoxication after an intentional overdose of amlodipine","volume":"47","author":"Rasmussen","year":"2003","journal-title":"Acta Anaesthesiol Scand"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.14562","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.14562","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.14562","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/30\/5\/1630\/66307067\/jvim14562.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/30\/5\/1630\/66307067\/jvim14562.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:12:24Z","timestamp":1770106344000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/30\/5\/1630\/8417235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.14562","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,9]]},"published":{"date-parts":[[2016,9,1]]}}}